OASIS Tears
- Product NDC
- 42126-6310
- 11-digit product format
- 421266310
- Labeler code
- 42126
- Product ID
- 42126-6310_5bc358cb-c2f9-49c7-a1db-5bec3e65ef5c
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Glycerin
- Dosage form
- SOLUTION/ DROPS
- Route
- OPHTHALMIC
- Labeler
- OASIS Medical, Inc.
- Application
- M018
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2010-01-09
- Substance
- GLYCERIN
- Active strength
- 2 g/1000mL
- Pharmacologic classes
- Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 42126-6310-1 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 42126-6310-1 | 0efc9e666f02… | f202fb6c5f17… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- OASIS Tears
- Brand name suffix
- Lubricant Eye
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| GLYCERIN | 2 g/1000mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| PDC6A3C0OX | Internal UNII lookup |
Harmonized RxCUI identifiers#
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 00071697-4ac6-4962-8eee-388b8b52bd40 | Available on FDA.report |
DailyMed Product Concepts#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 42126-6310-1 | OASIS TearsLubricant Eye | 10 mL in 1 BOTTLE, DISPENSING | SOLUTION/ DROPS | 10 | 7 | |
| 42126-6310-1 | OASIS TearsLubricant Eye | 1 in 1 CARTON | SOLUTION/ DROPS | 1 | 7 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 42126-6310 | OASIS TEARS LUBRICANT EYE (GLYCERIN) SOLUTION/ DROPS [OASIS MEDICAL, INC.] | 7 | Current NDC, Legacy NDC, 2 package rows | 20250124_00071697-4ac6-4962-8eee-388b8b52bd40.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| REFRESH OPTIVE | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | 7f8d88af-fd3b-4138-af61-f24c59ccebd7 | 2022-09-23 | Warnings | M018 |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, POLYSORBATE 80 | Allergan, Inc. | ebd0839e-2e1d-4e0e-986c-19f1f5c76358 | 2022-09-19 | Warnings | M018 |
| REFRESH OPTIVE Advanced | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN, AND POLYSORBATE 80 | Allergan, Inc. | aaa943e4-7c38-4c5a-b7c0-5a656d8cafc0 | 2022-09-01 | Warnings | M018 |
| REFRESH Optive Mega-3 | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN AND POLYSORBATE 80 | Allergan, Inc. | c5f2b3f2-2071-45bd-a010-67f848bc0233 | 2022-06-30 | Warnings | M018 |
| REFRESH P.M. | MINERAL OIL, PETROLATUM | Allergan, Inc. | 24365d64-cd94-41cc-a7e1-033102d98114 | 2022-06-30 | Warnings | M018 |
| REFRESH PLUS | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 0f6a4b4b-cde6-4518-84b5-ce997f1154a7 | 2022-06-28 | Warnings | M018 |
| REFRESH TEARS | CARBOXYMETHYLCELLULOSE SODIUM | Allergan, Inc. | 329d1fe0-4432-4565-b7b1-65666bd86526 | 2022-06-16 | Warnings | M018 |
| CIRCLE K sterile eye drops | TETRAHYDROZOLINE HCL | Lil' Drug Store Products, Inc. | 2c0e106c-16f6-ff4e-e063-6294a90a7dbb | 2018-07-30 | Warnings | M018 |
| Lil Drug Store Sterile Eye Drops Redness Reliever | TETRAHYDROZOLINE HCL | Lil' Drug Store Products, Inc. | 2c0ea35c-ac52-1043-e063-6394a90a061c | 2018-04-30 | Warnings | M018 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 998232 | glycerin 0.2 % Ophthalmic Solution | PSN | 00071697-4ac6-4962-8eee-388b8b52bd40 | 7 |
| 998236 | Oasis Tears Plus 0.2 % Ophthalmic Solution | PSN | 00071697-4ac6-4962-8eee-388b8b52bd40 | 7 |
| 998236 | glycerin 2 MG/ML Ophthalmic Solution [Oasis Tears] | SBD | 00071697-4ac6-4962-8eee-388b8b52bd40 | 7 |
| 998232 | glycerin 2 MG/ML Ophthalmic Solution | SCD | 00071697-4ac6-4962-8eee-388b8b52bd40 | 7 |
| 998232 | glycerin 0.2 % Ophthalmic Solution | SY | 00071697-4ac6-4962-8eee-388b8b52bd40 | 7 |
| 998236 | Oasis Tears 0.2 % Ophthalmic Drops | SY | 00071697-4ac6-4962-8eee-388b8b52bd40 | 7 |
| 998236 | Oasis Tears 2 MG/ML Ophthalmic Solution | SY | 00071697-4ac6-4962-8eee-388b8b52bd40 | 7 |
| 998236 | Oasis Tears Plus 0.2 % Ophthalmic Drops | SY | 00071697-4ac6-4962-8eee-388b8b52bd40 | 7 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|
| 42126-6310-1 | 42126631001 | 1 BOTTLE, DISPENSING in 1 CARTON (42126-6310-1) / 10 mL in 1 BOTTLE, DISPENSING | 2010-01-09 | 0000-00-00 | No | No | Current |